0001193125-26-371257 | 10-K | XBRL Viewer

Print Document

Income Taxes - Schedule of Unrecognized Tax Benefit (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Unrecognized Tax Benefits [Roll Forward]
Unrecognized Tax Benefits, Beginning Balance	$ 0	$ 389
Gross increases - tax positions in prior year	0	51
Gross decreases - tax positions in prior year	0	(53)
Gross increases - tax positions in current year	0	0
Settlement	0	(381)
Currency adjustment	0	(6)
Unrecognized Tax Benefits, Ending Balance	$ 0	$ 0

Commitments and Contingencies	12 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 16 — Commitments and Contingencies Contingencies The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June 30, 2026, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements. Legal Accruals In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company’s business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors. Other Matters In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

Commitments and Contingencies

12 Months Ended

Jun. 30, 2026

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 16 — Commitments and Contingencies

Contingencies

The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of June 30, 2026, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.

Legal Accruals

In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company’s business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.

Other Matters

In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482804/825-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-20/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-30/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Revenue - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
Revenue - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Revenue from External Customer [Line Items]
Deferred revenue	$ 1,148	$ 711
Increase (decrease) in revenue from recognition of deferred revenue	$ (400)	200
Money back guarantee period	30 days
Handling and restocking fee, percentage (as a percent)	10.00%
Return liability reserve	$ 200	$ 200
Protandim and TrueScience Product Line \| Revenue Benchmark \| Product Concentration Risk
Revenue from External Customer [Line Items]
Concentration risk percentage	83.30%	87.60%

Leases - Schedule of Lease Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating lease expense
Operating lease cost	$ 1,742	$ 1,881
Variable lease cost	119	154
Short-term lease costs	6	11
Total lease expense	$ 1,867	$ 2,046

Other Accrued Expenses - Schedule of Other Accreud Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Payables and Accruals [Abstract]
Accrued incentive compensation	$ 596	$ 5,325
Accrued severance	3	5
Other taxes payable	1,693	2,189
Accrued payable to vendors	810	459
Deferred revenue	1,148	711
Accrued incentives and promotions to consultants	1,590	3,284
Accrued other expenses	1,572	1,540
Total other accrued expenses	$ 7,412	$ 13,513

Income Taxes - Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]
Domestic	$ 4,971	$ 10,397
International	1,095	1,846
Income before income taxes	6,066	12,243
Current taxes
Federal	(127)	2,925
State	141	708
Foreign	603	491
Total current income tax provision	617	4,124
Deferred taxes
Federal	519	(1,464)
State	86	(341)
Foreign	(228)	119
Total deferred income tax expense	377	(1,686)
Net income tax provision	$ 994	$ 2,438

Leases

12 Months Ended

Jun. 30, 2026

Leases [Abstract]

Leases

Note 13 — Leases

The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of approximately one to six years. As of June 30, 2026, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.17 years and 3.29%, respectively. As of June 30, 2025, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.91 years and 3.17%, respectively.

The components of lease expense for the fiscal years ended June 30, 2026 and 2025, were as follows (in thousands):


	Year ended June 30,
	2026		2025
Operating lease expense
Operating lease cost	$	1,742	$	1,881
Variable lease cost		119		154
Short-term lease costs		6		11
Total lease expense	$	1,867	$	2,046

Supplemental cash flow information related to operating leases was as follows (in thousands):


	Year ended June 30,
	2026		2025
Operating cash outflows from operating leases	$	2,187	$	2,284
Right-of-use assets obtained in exchange for lease obligations	$	176	$	—

Maturity of lease liabilities at June 30, 2026 are as follows (in thousands):


Year ended June 30,	Amount
2027	$	2,223
2028		2,111
2029		1,772
2030		1,817
2031		1,862
Thereafter		943
Total		10,728
Less: imputed interest		(860	)
Present value of lease liabilities	$	9,868

Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (19,689)	$ (17,412)
Total property and equipment, net	7,310	6,207
Equipment (includes computer hardware and software)
Property, Plant and Equipment [Line Items]
Property and equipment, gross	20,436	16,998
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,467	1,469
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,045	5,101
Vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 51	$ 51

Related Party Transactions

12 Months Ended

Jun. 30, 2026

Related Party Transactions

Note 17 — Related Party Transactions

On February 23, 2026, the Company entered into a Securities Purchase Agreement with a stockholder who owns more than 10% of the Company’s issued and outstanding shares, to repurchase 0.1 million shares of common stock at a price of $0.5 million in exchange for cash. All shares were received and cash was transferred as of June 30, 2026.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

Acquisitions - Consideration Transferred and Assets Acquired (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 01, 2025	Jun. 30, 2026	Jun. 30, 2025
Business Combination [Line Items]
Cash consideration paid		$ 3,743	$ 0
Assets acquired:
Goodwill		$ 465	$ 0
LoveBiome
Business Combination [Line Items]
Cash consideration paid	$ 3,743
Earnout - current	200
Earnout - long-term	300
Total purchase price	4,243
Assets acquired:
Inventory	321
Other assets	257
Intangible assets	3,200
Total identifiable assets	3,778
Goodwill	$ 465

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Jun. 30, 2026
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2026

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense

The income tax expense consists of the following (in thousands):


	Year ended June 30,
	2026			2025
Income before income taxes:
Domestic	$	4,971		$	10,397
International		1,095			1,846
	$	6,066		$	12,243
Current taxes:
Federal	$	(127	)	$	2,925
State		141			708
Foreign		603			491
Total current income tax provision	$	617		$	4,124
Deferred taxes:
Federal	$	519		$	(1,464	)
State		86			(341	)
Foreign		(228	)		119
Total deferred income tax expense	$	377		$	(1,686	)
Net income tax provision	$	994		$	2,438

Schedule of The Effective Income Tax Rate Differs from the U.S. Federal Statutory Income Tax Rate

The effective income tax rate for the fiscal year ended June 30, 2026 differs from the U.S. Federal statutory income tax rate due to the following:


	Year ended June 30, 2026
Federal statutory income tax rate	$	1,274		21.0		%
Domestic state and local income taxes, net of federal effect(1)		214		3.5		%
Foreign tax rate differential		54		0.9		%

Non-taxable and non-deductible items
Meals and entertainment		95		1.6		%
Section 162(m) - Excess officer's compensation		137		2.2		%
Excess tax benefits on stock compensation		(250	)	(4.1	)	%
Other items, net		207		3.4		%
Total		189		3.1		%

Tax credits
Research and development credit		(555	)	(9.2	)	%
Foreign tax credit		(50	)	(0.8	)	%
Total		(605	)	(10.0	)	%

Cross-border tax laws, net		(131	)	(2.1	)	%

Change in valuation allowance		(1	)	-		%

Worldwide changes in unrecognized tax benefits		—		-		%

Net income tax provision	$	994		16.4		%

(1) The states making up 50% of the effect on the tax rate from state and local income tax effects are CA, MN, NE, TX, and UT.

The effective income tax rate for the fiscal year ended June 30, 2025 differs from the U.S. Federal statutory income tax rate is due to the following, based on the required disclosure prior to the adoption of ASU 2023-09:


	Year ended June 30, 2025
Federal statutory income tax rate		21.0		%
State income taxes, net of federal benefits		3.4		%
Foreign tax rate difference		(0.4	)	%
Tax return to provision true-up		0.4		%
Limit on future stock compensation due to 162(m)		4.0		%
Foreign withholding tax		0.8		%
Other differences		0.7		%
Revalue of deferred for change in federal tax rate		0.0		%
Permanent differences:
— stock-based compensation		(6.2	)	%
— current year section 162(m) limitation		0.9		%
— foreign derived intangible income deduction		(1.4	)	%
— tax credits		(4.8	)	%
— meals and entertainment		0.6		%
— removal of additional permanent reinvestment assertions		0.6		%
— change in uncertain tax positions		(0.4	)	%
— accrual for foreign tax audits		0.4		%
— other permanent differences		0.7		%
Change in valuation allowance		(0.4	)	%
Net income tax provision		19.9		%

Schedule of income taxes paid

The Company adopted ASU 2023-09 on a prospective basis for the fiscal year ended June 30, 2026 and have included the following table as a result of the adoption, which presents income taxes paid (net of refunds received) for the fiscal year ended June 30, 2026 (in thousands):


	Year ended June 30, 2026
US Federal	$	497

Domestic state and local		240

Foreign
Mexico		166
Australia		(87	)
Japan		129
Other		50
Total		258

Total	$	995

Schedule of The Components of the Deferred Tax Assets and Liabilities

The components of the deferred tax assets and liabilities as of June 30, 2026 and 2025 are as follows (in thousands):


	June 30,
	2026			2025
Deferred tax assets
Federal, state, and foreign net operating loss carryovers	$	218		$	234
Stock option compensation		332			628
Section 174 costs		3,099			2,798
Lease liability		2,538			2,798
Accrued vacation, allowance for returns, bonuses and other		2,849			2,819
Gross deferred tax asset	$	9,036		$	9,277

Deferred tax liabilities:
Patents and trademarks	$	(27	)	$	(16	)
Property & equipment		(170	)		(239	)
Right of use asset		(1,739	)		(1,942	)
Other		(843	)		(468	)
Gross deferred tax liabilities	$	(2,779	)	$	(2,665	)
Less: valuation allowance		(628	)		(642	)
Deferred tax asset, net	$	5,629		$	5,970

Schedule of Change In Liability For Uncertain Tax Positions

The change in the liability for uncertain tax positions were as follows (in thousands):


	Year ended June 30,
	2026		2025
Beginning balance	$	—	$	389
Gross increases - tax positions in prior year		—		51
Gross decreases - tax positions in prior year		—		(53	)
Gross increases - tax positions in current year		—		—
Settlement		—		(381	)
Currency adjustment		—		(6	)
Ending balance	$	—	$	—

Summary of Valuation Allowance

The change in the valuation allowance were as follows (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	642		$	720
Decreases		(14	)		(78	)
Ending balance	$	628		$	642

Long-Term Debt

12 Months Ended

Jun. 30, 2026

Debt Disclosure [Abstract]

Long-Term Debt

Note 8 — Long-Term Debt

On April 12, 2024, the Company entered into a Loan Agreement (the “Loan Agreement”), as amended, with Bank of America, N.A., as Lender (the “Lender”). In connection with the Loan Agreement and on the same date, the Company, Lifeline Nutraceuticals Corporation, as Guarantor (the “Guarantor”), and the Lender also entered into a Continuing and Unconditional Guaranty (the “Continuing and Unconditional Guaranty”) and a Security and Pledge Agreement (the “Security and Pledge Agreement”). The Loan Agreement provides for a revolving line of credit in an aggregate principal amount not to exceed $5.0 million (the “Line of Credit” and collectively with the Loan Agreement, Continuing and Unconditional Guaranty and the Security and Pledge Agreement the “2024 Credit Facility”).

On September 22, 2025, the Company entered into an amendment to the Loan Agreement, which amended the 2024 Credit Facility (“Amendment No. 1”) to allow proceeds from the credit facility to be also used for permitted acquisitions. On September 22, 2025, the Company also entered into a collateral assignment of, and grant of security interest in, the LoveBiome assets purchased by the Company.

In the event the Company borrows under the Line of Credit, interest will be payable commencing on the last day of each month following such borrowing until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the “Expiration Date”). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term Secured Overnight Financing Rate Daily Floating Rate (as defined in the Loan Agreement) or 0.00%, plus (ii) 2.00%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. As of June 30, 2026, the effective interest rate is 5.68%.

The Company’s obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, and by a pledge of the membership interests of the Company’s subsidiaries, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due.

The Loan Agreement contains customary covenants, both affirmative and negative, that, among other things, restrict the Company’s ability to deal with the Company’s assets outside of the ordinary course, incur additional indebtedness, grant liens on the Company’s assets, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, and enter into consolidations, mergers or other combinations. The Loan Agreement requires that the Company maintain specified financial ratios and satisfy certain financial condition tests.

The Loan Agreement contains certain customary events of default, including, among other things, failure of the Company to make required payments under the Loan Agreement, certain breaches of representations made by the Company or the Guarantor, insolvency or bankruptcy of the Company or the Guarantor, failure to have an enforceable first lien or security interest in any property given as security for the Loan Agreement, or failure of the Company to comply with covenants set forth in the Loan Agreement. If an event of default occurs under the Loan Agreement, the obligation of the Lender to make any additional credit available to the Company may be terminated and the amounts outstanding may become immediately due and payable in the discretion of the Lender, provided that in the event of insolvency or bankruptcy of the Company or the Guarantor, all debts outstanding under the Loan Agreement will automatically become due and payable. Upon the occurrence of any default or after maturity, all amounts outstanding under the Loan Agreement will, at the option of the Lender, bear interest at a rate which is 2.00% higher than the rate of interest otherwise provided under the Loan Agreement.

As of June 30, 2026, the Company was in compliance with its financial covenants under the 2024 Credit Facility. As of June 30, 2026, there was no balance outstanding on the 2024 Credit Facility.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Acquisitions - Intangible Assets Acquired (Details) - LoveBiome $ in Thousands	Oct. 01, 2025 USD ($)
Intangible Asset, Acquired, Finite-Lived [Line Items]
Amount (in thousands)	$ 3,200
Trade name
Intangible Asset, Acquired, Finite-Lived [Line Items]
Amount (in thousands)	$ 700
Useful Life (Years)	5 years
Know-how
Intangible Asset, Acquired, Finite-Lived [Line Items]
Amount (in thousands)	$ 300
Useful Life (Years)	5 years
Consultant sales force
Intangible Asset, Acquired, Finite-Lived [Line Items]
Amount (in thousands)	$ 2,200
Useful Life (Years)	7 years

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) shares in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Concentration Risk [Line Items]
Bad debt expenses	$ 0	$ 0
Impairment of intangible assets	0	0
Impairment of long-lived assets	0	0
Research and development	$ 1,000,000	$ 1,400,000
Antidilutive securities excluded from EPS calculation (in shares)	100	30
Cash accounts held primarily at One Financial Institution
Concentration Risk [Line Items]
Concentration of credit risk	$ 12,400,000	$ 17,000,000
Cash held primarily at Other Financial Institutions
Concentration Risk [Line Items]
Concentration of credit risk	$ 2,500,000	$ 3,200,000

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-18

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 310
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478785/954-310-50-2

+ Details

Acquisitions

12 Months Ended

Jun. 30, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Acquisitions

Note 15 — Acquisitions

On October 1, 2025, the Company closed on the purchase of critical assets of Global Organics Merchants, LLC, dba LoveBiome (“LoveBiome”) pursuant to an asset purchase agreement between the parties. LoveBiome was a direct sales company focused on comprehensive microbiome care and wellness solutions. The acquisition is being accounted for as a business combination in accordance with ASC 805.

The Company has made an allocation of the purchase price of the business combination to the assets acquired as of the closing date. No liabilities were assumed. The following table summarizes the purchase price allocations relating to the business combination (in thousands):


	Valuation
Cash consideration paid	$	3,743
Earnout - current		200
Earnout - long-term		300
Total purchase price	$	4,243
Assets acquired:
Inventory	$	321
Other assets		257
Intangible assets		3,200
Total identifiable assets		3,778
Goodwill	$	465

The earnout payments are contingent upon revenue targets of the Company for the fiscal year ending June 30, 2026, as well as LoveBiome standalone revenue targets ending on the first and second anniversaries of the closing date. The fair value of the earnout was estimated using a Monte Carlo simulation option method.

The assets acquired were recognized at their estimated acquisition-date fair values, with goodwill representing the excess of the purchase price over the fair value of the identifiable assets acquired. The purchase price includes the fair values of other assets that were not identifiable, not separately recognizable under GAAP (e.g., assembled workforce) or of immaterial value. The goodwill of $0.5 million arising from the acquisition consists largely of the synergies and economies of scale expected from combining the operations of the Company and LoveBiome. All of the goodwill was assigned to the single operating segment. Part of the goodwill recognized will be amortized for tax purposes and more may become amortizable as the earnouts are paid. In addition, certain legal costs have been capitalized as goodwill for tax purposes and are being amortized.

Under ASC 740, the Company is required to recognize part of the identified goodwill as deferred taxes. Therefore, the carrying value of goodwill was reduced to $465,000 and $57,000 was recorded to deferred taxes as of June 30, 2026. The total amount of goodwill expected to be deductible for tax purposes is $0.2 million.

The Company recorded changes in fair value of the estimated earnout consideration to be achieved (as a result of lower than forecasted revenue performance). The change in estimates resulted in a reversal $0.4 million during the fiscal year ended June 30, 2026, and is recorded in selling, general, and administrative expenses. As of June 30, 2026, the total estimated earnout was $0.1 million.

During the fiscal year ended June 30, 2026, the Company incurred approximately $0.2 million in acquisition-related costs associated with the LoveBiome transaction, which are recorded in selling, general, and administrative expenses in the Company's consolidated statements of operations.

In connection with the acquisition of LoveBiome, the Company identified and valued the following intangible assets:


Category	Amount (in thousands)		Useful Life (Years)
Trade name	$	700		5
Know-how		300		5
Consultant sales force		2,200		7
Total acquired identifiable intangible assets(1)	$	3,200

(1) The fair value was determined using Level 3 assumptions.

The fair values of the trade name and know-how were determined based on the relief-from-royalty method, a form of the income approach, using royalty rates of 1.5% and 1.0%, respectively. The fair value of the consultant sales force was estimated based on the present value of incremental after-tax cash flows, discounted at 28.5%.

Amortization expense related to acquired intangible assets was $0.4 for the fiscal year ended June 30, 2026.

Unaudited supplemental information on a pro forma basis, as if the LoveBiome transaction had been consummated on July 1, 2024, is as follows (in thousands):


	Year ended June 30,
	2026		2025
Revenue	$	185,124	$	237,293
Earnings		5,019		10,158

The unaudited pro forma supplemental information is based on estimates and assumptions, which the Company believes are reasonable. These results are not necessarily indicative of the Company’s consolidated financial condition or statements of operations in future periods or the results that actually would have been realized had the Company and LoveBiome been a combined entity during the periods presented. These pro forma amounts have been calculated after applying the following adjustments that were directly attributable to the LoveBiome transaction:

•

The supplemental pro forma earnings for fiscal year ended June 30, 2026 were adjusted to exclude the $0.2 million in acquisition-related costs associated with the LoveBiome transaction, and instead, these costs are reflected in the pro forma earnings for the fiscal year ended June 30, 2025.

•

These pro forma amounts have been calculated after applying the Company's accounting policies and adjusting the results of LoveBiome to reflect additional amortization that would have been charged assuming the fair value adjustments to intangible assets had been applied from July 1, 2024, as well as adjustments to other selling, general, and administrative expenses for contracts that were not assumed in this transaction, with the consequential tax effects.

Total revenue related to LoveBiome consultants from the date of acquisition to June 30, 2026 was $6.3 million. Determining earnings from the date of acquisition is impracticable as LoveBiome has been fully integrated into the Company and costs are not segregated between LoveBiome and the legacy LifeVantage business.

- Definition

The entire disclosure for business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-38

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 46
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-46

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 43
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-43

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 45
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-45

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-4

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 40
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479326/805-40-45-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-30/tableOfContent

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-20/tableOfContent

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-10/tableOfContent

+ Details

The Company - Narrative (Details) - $ / shares	Jun. 30, 2026	Jun. 30, 2025	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common stock, par value (in USD per share)	$ 0.0001	$ 0.0001	$ 0.0001

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 0.4	$ 0.1
Definite-lived intangible assets weighted-average amortization period	5 years 8 months 12 days

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-11

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-24

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-12

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-6

+ Details

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities:
Net Income (Loss)	$ 5,072	$ 9,805
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	2,773	3,156
Stock-based compensation	2,346	5,702
Non-cash operating lease expense	1,389	1,440
Loss (gain) on disposal of assets	7	(4)
Amortization of debt discount	39	32
Allowance for inventory obsolescence	2,721	0
Change in fair value of earnout consideration	(400)	0
Deferred income tax	400	(1,703)
Changes in operating assets and liabilities:
Accounts receivable	200	(242)
Income tax receivable	(751)	(322)
Inventory, net	2,019	(5,216)
Prepaid expenses and other	3,225	(3,603)
Other long-term assets	(85)	72
Accounts payable	588	(1,295)
Income tax payable	146	(201)
Other accrued expenses	(7,278)	6,037
Lease liabilities	(1,868)	(1,843)
Other liabilities	(302)	63
Net Cash Provided by Operating Activities	10,241	11,878
Cash Flows from Investing Activities:
Proceeds from sale of property and equipment	0	4
Cash paid for business combination	(3,743)	0
Purchase of property and equipment	(3,571)	(1,371)
Net Cash Used in Investing Activities	(7,314)	(1,367)
Cash Flows from Financing Activities:
Proceeds from revolving credit facility	2,500	0
Principal payments of revolving credit facility	(2,500)	0
Payment of deferred financing fees	(12)	0
Repurchase of company stock	(2,043)	(3,147)
Payment of cash dividends	(2,344)	(2,067)
Shares canceled or surrendered as payment of tax withholding and other	(3,616)	(2,664)
Proceeds from common stock issued under employee stock purchase plan	232	280
Net Cash Used in Financing Activities	(7,783)	(7,598)
Foreign Currency Effect on Cash	(425)	402
Increase (Decrease) in Cash and Cash Equivalents:	(5,281)	3,315
Cash and Cash Equivalents — beginning of period	20,201	16,886
Cash and Cash Equivalents — end of period	14,920	20,201
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	11	2
Cash paid for income taxes	$ 995	$ 4,918

The Company

12 Months Ended

Jun. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The Company

Note 1 — The Company

LifeVantage Corporation (the “Company” or “we” or “our” or “us”) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to its independent consultants. LifeVantage sells its products in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, Iceland, and Portugal. The Company closed its market in the Philippines in June 2025 and closed its markets in Hong Kong and Singapore in May 2026. The Company also sells its products in a number of countries to consumers for personal consumption only.

The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products and nootropics. The Company’s line of scientifically validated dietary supplements includes its flagship Protandim® family of products, its LifeVantage® line of dietary supplements that include the MindBody GLP-1 System®, Omega+, ProBio, IC Bright®, the Rise AM & Reset PM System®, D3+, Daily Wellness, Fat Burn, Prebiotic, and Carb Block dietary supplements. TrueScience® is the Company’s line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs; AXIO®, its nootropic and energy/hydration drink mixes; and the P84 System, which was acquired from LoveBiome in connection with the Company's October 2025 acquisition.

The Company was incorporated in Colorado in June 1988 under the name Andraplex Corporation. The Company changed its corporate name to Yaak River Resources, Inc. in January 1992, and subsequently changed it again in October 2004 to Lifeline Therapeutics, Inc. In October 2004 and March 2005, the Company acquired all of the outstanding common stock of Lifeline Nutraceuticals Corporation. In November 2006, the Company changed its name to LifeVantage Corporation.

In March 2018, the Company reincorporated from the state of Colorado to the state of Delaware. All outstanding shares of common stock, options and share units of the Colorado corporation were converted into an equivalent share, option or share unit of the Delaware corporation and the par value of the Company’s common stock was adjusted to $0.0001.

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 2.4	$ 3.1

Summary of Significant Accounting Policies - Property and Equipment (Details)	Jun. 30, 2026
Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	3 years
Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years
Vehicles
Property, Plant and Equipment [Line Items]
Estimated service lives of property and equipment	5 years

Other Expense, Net - Scheduel of Other Expense, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Other Income and Expenses [Abstract]
Foreign currency transaction loss, net	$ (200)	$ (380)
Other income (expense), net	2	(7)
Total other expense, net	$ (198)	$ (387)

Revenue - Sales Return (Details) - Sales Returns and Allowances - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ 237	$ 133
Additions	2,385	2,759
Returns	(2,449)	(2,655)
Ending balance	$ 173	$ 237

Leases - Narrative (Details)	Jun. 30, 2026	Jun. 30, 2025
Lessee, Lease, Description [Line Items]
Weighted average remaining lease term	5 years 2 months 1 day	5 years 10 months 28 days
Weighted average discount rate (as a percent)	3.29%	3.17%
Minimum
Lessee, Lease, Description [Line Items]
Lease term	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lease term	6 years

Income Taxes - Schedule of income taxes paid (Details) $ in Thousands	12 Months Ended
	Jun. 30, 2026 USD ($)
Income Tax Paid, by Individual Jurisdiction [Line Items]
US Federal	$ 497
Domestic state and local	240
Foreign, Total	258
Income Taxes Paid, Net, Total	995
MEXICO
Income Tax Paid, by Individual Jurisdiction [Line Items]
Foreign, Total	166
AUSTRALIA
Income Tax Paid, by Individual Jurisdiction [Line Items]
Foreign, Total	(87)
JAPAN
Income Tax Paid, by Individual Jurisdiction [Line Items]
Foreign, Total	129
Other
Income Tax Paid, by Individual Jurisdiction [Line Items]
Foreign, Total	$ 50

Stockholders' Equity

12 Months Ended

Jun. 30, 2026

Equity [Abstract]

Stockholders' Equity

Note 9 — Stockholders’ Equity

During the fiscal years ended June 30, 2026 and 2025, the Company issued 0.7 million and 0.4 million shares of common stock, respectively, under Company stock plans. During the fiscal years ended June 30, 2026 and 2025, 0.3 million and 0.2 million shares of restricted stock, respectively, were canceled or surrendered as payment of tax withholding upon vesting of equity awards. During the fiscal years ended June 30, 2026 and 2025, the Company issued zero shares of common stock upon the exercise of stock options.

In January 2026, the Company’s board of directors (the “Board of Directors”) approved a new stock repurchase program, which replaced the Company’s previous stock repurchase program in its entirety to repurchase up to $60.0 million in shares of common stock through December 31, 2027. During the fiscal years ended June 30, 2026 and 2025, the Company purchased 0.3 million and 0.3 million shares of common stock at an aggregate price of $2.0 million and $3.1 million, respectively, under the applicable repurchase program. At June 30, 2026, there was $58.5 million remaining under the new stock repurchase program.

On August 30, 2023, the Board of Directors approved a stockholder rights agreement (the “Rights Plan”) and declared a dividend of one right for each outstanding share of common stock to stockholders of record on September 11, 2023. Each right entitled holders to purchase one newly issued share of preferred stock at an exercise price of $20 per right, subject to adjustment. Initially, the rights were not exercisable and traded with shares of the Company’s common stock.

In general, the rights would have become exercisable following a public announcement that a person had acquired 12% (or, in the case of passive investors, 20%) or more of the outstanding shares of the Company’s common stock. If a person became an acquiring person, each holder of rights (except the acquiring person) would have had the right to purchase, for the purchase price, a number of shares of the Company’s common stock at a 50% discount to the then-current trading price. Rather than allowing the rights to be exercised in those circumstances, the Board of Directors could exchange each right, other than the rights owned by the acquiring person, for a share of the Company’s common stock. The agreement provided for exceptions and additional terms for other certain situations and circumstances.

The Rights Plan was intended to protect the interests of LifeVantage and its stockholders by reducing the likelihood that any entity, person or group gains control of the Company through open-market accumulation or other means without payment of an adequate control premium and expired on August 28, 2024. There was no impact to the Company’s Consolidated Financial Statements.

The Company’s Certificate of Incorporation authorizes the designation and issuance of preferred stock. However, as of June 30, 2026, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Board of Directors.

Dividends

The Company paid quarterly cash dividends of $0.045 per share of common stock to stockholders of record in September 2025, December 2025 and March 2026, and $0.05 per share of common stock to stockholders of record in June 2026 which were in the aggregate amount of $2.3 million, or $0.185 per share of common stock for the fiscal year ended June 30, 2026.

The Company paid quarterly cash dividends of $0.04 per share of common stock to stockholders of record in September 2024, December 2024 and March 2025, and $0.045 per share of common stock to stockholders of record in June 2025 which were in the aggregate amount of $2.1 million, or $0.165 per share of common stock for the fiscal year ended June 30, 2025.

The declaration of dividends is subject to the discretion of the Board of Directors and will depend upon various factors, including the Company’s earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Board of Directors.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

Long-Term Debt (Details) - Revolving Credit Facility - USD ($)	Apr. 12, 2024	Jun. 30, 2026
Line of Credit
Line of Credit Facility [Line Items]
Effective rate		5.68%
2024 Credit Facility
Line of Credit Facility [Line Items]
Expiration date	Apr. 12, 2027
Floor interest rate (as a percent)	0.00%
Basis spread on variable rate (as a percent)	2.00%
Outstanding balance		$ 0
2024 Credit Facility \| Line of Credit
Line of Credit Facility [Line Items]
Maximum capacity on draw	$ 5,000,000

Summary of Significant Accounting Policies

12 Months Ended

Jun. 30, 2026

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of Estimates

The Company prepares the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, stock-based compensation, and loss contingencies.

Foreign Currency Translation

A portion of the Company’s business operations occurs outside the United States. The local currency of each of the Company’s subsidiaries is generally its functional currency. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive income.

Fair Value of Financial Instruments

The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.

•

Level 1—Quoted prices for identical instruments in active markets;

•

Level 2—Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

•

Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature.

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less as cash equivalents.

Concentration of Credit Risk

Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At June 30, 2026, the Company had $12.4 million in cash accounts at one financial institution and $2.5 million in accounts at other financial institutions. At June 30, 2025, the Company had $17.0 million in cash accounts at one financial institution and $3.2 million in accounts at other financial institutions. As of June 30, 2026 and 2025 and during the periods then ended, the Company’s cash balances exceeded federally insured limits.

Accounts Receivable

The Company’s accounts receivable for the fiscal years ended June 30, 2026 and 2025 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of June 30, 2026 and 2025 is not necessary. There was no bad debt expense for the fiscal years ended June 30, 2026 and 2025.

Inventory

Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method. To estimate any necessary adjustments, various assumptions are made regarding excess or slow-moving inventories, expiration dates, current and future product demand, and market conditions. If future demand and market conditions are less favorable than the Company's assumptions, additional inventory adjustments could be required.

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


				Years
Equipment				3 - 5
Furniture and fixtures				5
Vehicles				5

Leasehold improvements are depreciated over the shorter of estimated useful life of the related asset or the lease term. The cost of normal maintenance and repairs is charged to expense as incurred. When an asset is sold or otherwise disposed of, the cost and associated accumulated depreciation are removed from the accounts and the resulting gain or loss is recognized in the consolidated statements of operations and comprehensive income in other expense, net. Significant expenditures that increase the useful life of an asset are capitalized and depreciated over the estimated useful life of the asset. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.

Goodwill and Intangible Assets

Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. Finite-lived intangible assets are stated at cost less accumulated amortization. Finite-lived intangible assets are amortized over their related useful lives, using a straight-line method, consistent with the underlying expected future cash flows related to the specific intangible asset. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances exist that indicate the carrying amount of an asset may not be recoverable. When indicators of impairment exist, an estimate of undiscounted net cash flows is used in measuring whether the carrying amount of the asset or related asset group is recoverable. Measurement of the amount of impairment, if any, is based upon the difference between the asset’s carrying value and estimated fair value. Indefinite-lived intangible assets are not amortized; however, they are tested at least annually for impairment or more frequently if events or changes in circumstances exist that may indicate impairment. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Annual impairment tests on intangible assets were completed for the fiscal years ended June 30, 2026 and 2025, resulting in no impairment charges.

Impairment of Long-Lived Assets

Pursuant to guidance established for impairment or disposal of assets, the Company assesses impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. When an assessment for impairment of long-lived assets, long-lived assets to be disposed of, and certain identifiable intangibles related to those assets is performed, the Company is required to compare the net carrying value of long-lived assets on the lowest level at which cash flows can be determined on a consistent basis to the related estimates of future undiscounted net cash flows for such assets. If the net carrying value exceeds the net cash flows, then an impairment is recognized to reduce the carrying value to the estimated fair value, generally equal to the future discounted net cash flow. For the fiscal years ended June 30, 2026 and 2025, management has concluded that there are no indications of impairment.

Shipping and Handling

Shipping and handling costs associated with inbound freight and freight out to customers and independent consultants are included in cost of sales. Shipping and handling fees charged to customers and independent consultants are included in revenue.

Commissions and Incentives

Commissions and incentives expenses are the Company’s most significant expenses and are classified as operating expenses. Commissions and incentives expenses include sales commissions paid to the Company’s independent consultants, special incentives, costs for incentive trips and other rewards. Commissions and incentives expenses do not include any amounts the Company pays to its independent consultants for personal purchases. Commissions paid to independent consultants on personal purchases are considered a sales discount and are reported as a reduction to net revenue.

Research and Development Costs

The Company expenses all costs related to research and development activities, as incurred. Research and development expenses for the fiscal years ended June 30, 2026 and 2025 were $1.0 million and $1.4 million, respectively.

Stock-Based Compensation

The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. The Company estimates forfeitures based on historical information and other management assumptions.

The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company’s 2019 Employee Stock Purchase Plan (as amended, the “2019 ESPP”). The determination of the fair value of options is affected by the Company’s stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.

The fair value of restricted stock grants, including performance restricted stock units that include non-market based performance conditions, is based on the closing market price of the Company’s stock on the date of grant less the Company’s expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sustained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.

Income Per Share

Basic income per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.

For the fiscal years ended June 30, 2026 and 2025, the effects of approximately 0.1 million and 30,000 common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive.

The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):


	Year ended June 30,
	2026		2025
Numerator:
Net income	$	5,072	$	9,805
Denominator:
Basic weighted-average common shares outstanding		12,534		12,251
Effect of dilutive securities:
Stock awards and options		168		736
Diluted weighted-average common shares outstanding		12,702		12,987
Net income per share, basic	$	0.40	$	0.80
Net income per share, diluted	$	0.40	$	0.75

New Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company’s annual periods beginning July 1, 2025. The Company adopted this standard prospectively and included the additional required disclosures for the fiscal year ended June 30, 2026. See Note 12 - Income Taxes for further information.

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). The guidance requires disclosure, in the notes to financial statements, of specific information about certain costs and expenses at each interim and annual reporting period. ASU 2024-03 is effective for the Company’s annual periods beginning July 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. (“ASU 2025-06”). The amendments in this ASU are intended to improve the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods, including methods that entities may use to develop software in the future. Therefore, the amendments require that an entity capitalize software costs when both: management has authorized and committed to funding the software project; and it is probable that the project will be completed and the software will be used to perform the function intended. The Company has elected to early adopt ASU 2025-06 for the current fiscal year and transitioned using the prospective transition approach.

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2026	Jun. 30, 2025
Operating Loss Carryforwards [Line Items]
Increase resulting from foreign tax audits		$ 0.4
Tax benefit from settlement of stock based awards	$ 0.2	$ 0.8
Open tax years	2022 2023 2024 2025
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 4.8
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 0.3

Summary of Significant Accounting Policies - Reconciliation of Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Numerator:
Net Income (Loss)	$ 5,072	$ 9,805
Denominator:
Basic weighted-average common shares outstanding (in shares)	12,534	12,251
Effect of dilutive securities:
Stock awards and options (in shares)	168	736
Diluted weighted-average common shares outstanding (in shares)	12,702	12,987
Net income per share, basic (in USD per share)	$ 0.4	$ 0.8
Net income per share, diluted (in USD per share)	$ 0.4	$ 0.75

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3A
-Subparagraph (24)(d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 30, 2026
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Income Taxes

12 Months Ended

Jun. 30, 2026

Income Tax Disclosure [Abstract]

Income Taxes

Note 12 — Income Taxes

The income tax expense consists of the following (in thousands):


	Year ended June 30,
	2026			2025
Income before income taxes:
Domestic	$	4,971		$	10,397
International		1,095			1,846
	$	6,066		$	12,243
Current taxes:
Federal	$	(127	)	$	2,925
State		141			708
Foreign		603			491
Total current income tax provision	$	617		$	4,124
Deferred taxes:
Federal	$	519		$	(1,464	)
State		86			(341	)
Foreign		(228	)		119
Total deferred income tax expense	$	377		$	(1,686	)
Net income tax provision	$	994		$	2,438

The Company adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, on a prospective basis beginning with the fiscal year ended June 30, 2026. The effective income tax rate for the fiscal year ended June 30, 2026 differs from the U.S. Federal statutory income tax rate due to the following:


	Year ended June 30, 2026
Federal statutory income tax rate	$	1,274		21.0		%
Domestic state and local income taxes, net of federal effect(1)		214		3.5		%
Foreign tax rate differential		54		0.9		%

Non-taxable and non-deductible items
Meals and entertainment		95		1.6		%
Section 162(m) - Excess officer's compensation		137		2.2		%
Excess tax benefits on stock compensation		(250	)	(4.1	)	%
Other items, net		207		3.4		%
Total		189		3.1		%

Tax credits
Research and development credit		(555	)	(9.2	)	%
Foreign tax credit		(50	)	(0.8	)	%
Total		(605	)	(10.0	)	%

Cross-border tax laws, net		(131	)	(2.1	)	%

Change in valuation allowance		(1	)	-		%

Worldwide changes in unrecognized tax benefits		—		-		%

Net income tax provision	$	994		16.4		%

(1) The states making up 50% of the effect on the tax rate from state and local income tax effects are CA, MN, NE, TX, and UT.


	Year ended June 30, 2025
Federal statutory income tax rate		21.0		%
State income taxes, net of federal benefits		3.4		%
Foreign tax rate difference		(0.4	)	%
Tax return to provision true-up		0.4		%
Limit on future stock compensation due to 162(m)		4.0		%
Foreign withholding tax		0.8		%
Other differences		0.7		%
Revalue of deferred for change in federal tax rate		0.0		%
Permanent differences:
— stock-based compensation		(6.2	)	%
— current year section 162(m) limitation		0.9		%
— foreign derived intangible income deduction		(1.4	)	%
— tax credits		(4.8	)	%
— meals and entertainment		0.6		%
— removal of additional permanent reinvestment assertions		0.6		%
— change in uncertain tax positions		(0.4	)	%
— accrual for foreign tax audits		0.4		%
— other permanent differences		0.7		%
Change in valuation allowance		(0.4	)	%
Net income tax provision		19.9		%


	Year ended June 30, 2026
US Federal	$	497

Domestic state and local		240

Foreign
Mexico		166
Australia		(87	)
Japan		129
Other		50
Total		258

Total	$	995

The components of the deferred tax assets and liabilities as of June 30, 2026 and 2025 are as follows (in thousands):


	June 30,
	2026			2025
Deferred tax assets
Federal, state, and foreign net operating loss carryovers	$	218		$	234
Stock option compensation		332			628
Section 174 costs		3,099			2,798
Lease liability		2,538			2,798
Accrued vacation, allowance for returns, bonuses and other		2,849			2,819
Gross deferred tax asset	$	9,036		$	9,277

Deferred tax liabilities:
Patents and trademarks	$	(27	)	$	(16	)
Property & equipment		(170	)		(239	)
Right of use asset		(1,739	)		(1,942	)
Other		(843	)		(468	)
Gross deferred tax liabilities	$	(2,779	)	$	(2,665	)
Less: valuation allowance		(628	)		(642	)
Deferred tax asset, net	$	5,629		$	5,970

The Company has adopted accounting guidance for uncertain tax positions (“UTPs”) which provides that in order to recognize an uncertain tax benefit, the taxpayer must be more likely than not of sustaining the position. The measurement of the benefit is calculated as the largest amount that is more than 50% likely to be realized upon recognition of the benefit.

In the fiscal year ended June 30, 2024, the Company began recording a withholding tax obligation on certain rebalanced commission payments to the U.S. parent company it had not obtained treaty rates for. The withholding tax recorded in the fiscal year ended June 30, 2024 has been reversed during the fiscal year ended June 30, 2025 as the Company no longer expects to pay that liability.

The Company has been undergoing income tax audits in foreign jurisdictions. For the fiscal year ended June 30, 2025, the Company accrued a total $0.4 million related to foreign income tax audits. In fiscal year 2025, the Company made payments or deemed payments totaling $0.4 million related to these foreign income tax audits. The Company also increased the amount of the UTP relating to the prior year to reflect the actual payments that were made. The UTP related to foreign tax audits is zero

for the fiscal years ended June 30, 2026 and 2025. The Company does not have any other foreign tax audits underway as of June 30, 2026.

The change in the liability for uncertain tax positions were as follows (in thousands):


	Year ended June 30,
	2026		2025
Beginning balance	$	—	$	389
Gross increases - tax positions in prior year		—		51
Gross decreases - tax positions in prior year		—		(53	)
Gross increases - tax positions in current year		—		—
Settlement		—		(381	)
Currency adjustment		—		(6	)
Ending balance	$	—	$	—

In fiscal year 2022, the Company removed its permanent reinvestment assertion in Japan. In fiscal year 2024, the Company removed its permanent reinvestment assertions in Taiwan and Australia and recorded the tax effects of that change. In fiscal year 2025, the Company removed its permanent reinvestment assertion on all other entities. In fiscal year 2026, the Company recorded the 986(c) adjustment related to the unrepatriated earnings. This adjustment largely reflects the significant change in the foreign currency rate between the United States and Japan on Japan's previously taxed earnings and profits ("PTEP").

The Company recorded all tax effects of these changes as discrete items. The Company has minor PTEP and most future dividends will be excluded under the United States Internal Revenue Code Section 245A. The withholding tax and state tax implications are minimal.

The change in the valuation allowance were as follows (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	642		$	720
Decreases		(14	)		(78	)
Ending balance	$	628		$	642

The change in valuation allowance during the fiscal year ended June 30, 2026 primarily related to small changes in foreign entities with full valuation allowances. The change in valuation allowance during the fiscal year ended June 30, 2025 related to a decrease in the valuation allowance on state net operating losses ("NOLs"). Due to higher projected taxable income, the Company felt it was appropriate to reduce the valuation allowance. There were also insignificant changes in other entities with full valuation allowances.

As of June 30, 2026, the Company had utilized all of its Federal NOL carry-forwards. As of June 30, 2026, state NOLs were $4.8 million and foreign NOLs were $0.3 million.

The total recognized tax benefit from settlement of stock-based awards for the fiscal years ended June 30, 2026 and 2025, was $0.2 million and $0.8 million, respectively.

The Company has reflected all changes in tax laws including the changes resulting from expiring Tax Cuts and Jobs Act provisions that were effective for the fiscal year ended June 30, 2026.

The Company conducts its business globally. As a result, the Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and are subject to examination for the open tax years of June 30, 2022 through June 30, 2025.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Share-Based Compensation (Tables)

12 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity

The following is a summary of stock option activity for the fiscal years ended June 30, 2026 and 2025:


	Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2024		72	$	4.44

Granted		—		—
Exercised		—		—			$	—
Forfeited		—		—
Expired or Canceled		—		—
Outstanding at June 30, 2025		72		4.44

Granted		—		—
Exercised		—		—			$	—
Forfeited		—		—
Expired or Canceled		—		—
Outstanding at June 30, 2026		72		4.44		1.59	$	129
Exercisable at June 30, 2026		72	$	4.44		1.59	$	129

Schedule of Nonvested Restricted Shares

The following is a summary of restricted stock award activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		392		$	4.74

Granted		58		$	13.54
Vested		(294	)		4.77
Forfeited		—			—
Nonvested at June 30, 2025		156			7.92

Granted		81		$	6.75
Vested		(143	)		8.19
Forfeited		(13	)		4.89
Nonvested at June 30, 2026		81			6.75

Schedule of Unvested Restricted Stock Units Roll Forward

The following is a summary of restricted stock units activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		337		$	4.86

Granted		224		$	10.08
Vested		(224	)		4.87
Forfeited		(47	)		6.12
Nonvested at June 30, 2025		290			8.68

Granted		243		$	9.95
Vested		(160	)		7.46
Forfeited		(153	)		11.82
Nonvested at June 30, 2026		220			8.78

Summary of Nonvested Restricted Stock Units

The following is a summary of performance restricted stock units activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		284		$	4.62

Granted (1)		509		$	8.30
Vested		(94	)		4.24
Forfeited		(45	)		6.67
Nonvested at June 30, 2025		654			7.40

Granted		189		$	12.47
Vested		(462	)		7.25
Forfeited		(305	)		9.87
Nonvested at June 30, 2026		76			10.95

(1) Includes shares added based on achievement of performance goals in excess of target.

Other Accrued Expenses

12 Months Ended

Jun. 30, 2026

Payables and Accruals [Abstract]

Other Accrued Expenses

Note 7 — Other Accrued Expenses

Other accrued expenses consist of (in thousands):


	June 30,
	2026		2025
Accrued incentive compensation	$	596	$	5,325
Accrued severance		3		5
Other taxes payable		1,693		2,189
Accrued payable to vendors		810		459
Deferred revenue		1,148		711
Accrued incentives and promotions to consultants		1,590		3,284
Accrued other expenses		1,572		1,540
Total other accrued expenses	$	7,412	$	13,513

Inventory - Schedule of Components of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Inventory Disclosure [Abstract]
Finished goods	$ 11,962	$ 17,739
Raw materials	4,205	2,930
Total inventory	$ 16,167	$ 20,669
Finished goods, percent of inventory (in percentage)	74.00%	85.80%
Raw materials, percent of inventory (in percentage)	26.00%	14.20%
Percent of total inventory (in percentage)	100.00%	100.00%

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2026	Jun. 30, 2025
Statement of Financial Position [Abstract]
Preferred stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	12,518,000	12,429,000
Common stock, shares outstanding (in shares)	12,518,000	12,429,000

Intangible Assets, Net

12 Months Ended

Jun. 30, 2026

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets, Net

Note 6 — Intangible Assets, Net

Intangible assets, net consist of (in thousands):


	June 30,
	2026			2025
Trade name	$	700		$	—
Know-how		300			—
Consultant sales force		2,200			—
Accumulated amortization		(387	)		—
		2,813			—

Trademarks and other indefinite-lived intangible assets		245			245
Total intangible assets, net	$	3,058		$	245

Amortization expense totaled $0.4 million and $0.1 million for the fiscal years ended June 30, 2026 and 2025, respectively. As of June 30, 2026, the remaining weighted-average amortization period for finite-lived intangible assets is 5.7 years.

Annual amortization expense expected for each of the five succeeding fiscal years is as follows (in thousands):


Year ended June 30,	Amount
2027	$	514
2028		514
2029		514
2030		514
2031		364
Thereafter		393
Total	$	2,813

Revenue

12 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Abstract]

Revenue

Note 3 — Revenue

Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.

The Company generates the majority of its revenue through product sales to customers. These products include the Protandim® line of dietary supplements, the LifeVantage® line of dietary supplements that include the MindBody GLP-1 System®, Omega+, ProBio, IC Bright®, the Rise AM & Reset PM System®, D3+, Daily Wellness, Fat Burn, Prebiotic and Carb Block dietary supplements, TrueScience® skin and hair care products and Liquid Collagen, Petandim®, our companion pet supplement formulated to combat oxidative stress in dogs, AXIO® nootropic and energy/hydrate drink mixes, and the P84 System formulated to regulate, repair, and restore gut health. The Company ships most of its product directly to the consumer

and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.

The Company also charges amounts to independent consultants to attend events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis, adjusted for the probability of the tickets being redeemed for attendance at a future event. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.

Deferred Revenue

The Company launched its Rewards Circle loyalty program in the United States, Australia, New Zealand, and Japan in March 2023 and in Canada, Europe, and Mexico in February 2024. Contract liabilities, recorded as deferred revenue, include these loyalty program credit deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as credits are redeemed for additional products at a later date.

In December 2025, the Company introduced an annual fee for independent consultants in certain markets that includes access to the lowest price on products, commissions management, training resources, back-office reporting, and support tools. Revenue is recognized on a straight-line basis over the twelve month period following payment of the annual fee. Unrecognized revenue is recorded as deferred revenue.

The Company also records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The Company pre-sells tickets to its events. When cash payments are received in advance of events, the cash received is recorded to deferred revenue until the event is held, at which time the Company has performed its obligations under the contract and the revenue is recognized.

Deferred revenue is included in accrued expenses in the consolidated balance sheets. The balance of deferred revenue related to contract liabilities, each less than twelve months, was $1.1 million and $0.7 million as of June 30, 2026 and 2025, respectively. The contract liabilities impact to revenue for the fiscal years ended June 30, 2026 and 2025 was a decrease of $0.4 million and an increase of $0.2 million, respectively.

Sales Returns and Allowances

Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company’s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of June 30, 2026 and 2025, the Company’s return liability reserve, net was $0.2 million and $0.2 million, respectively.

Reserves for sales returns consist of the following (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	237		$	133
Additions		2,385			2,759
Returns		(2,449	)		(2,655	)
Ending balance	$	173		$	237

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

Share-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Nonvested, Beginning balance	654	284
Shares, Granted	189	509
Shares, Vested	(462)	(94)
Shares, Forfeited	(305)	(45)
Shares Nonvested, Ending Balance	76	654
Weighted Average Grant Date Fair Value, Nonvested, Beginning balance	$ 7.4	$ 4.62
Weighted Average Grant Date Fair Value, Granted	12.47	8.3
Weighted Average Grant Date Fair Value, Vested	7.25	4.24
Weighted Average Grant Date Fair Value, Forfeited	9.87	6.67
Weighted Average Grant Date Fair Value, Nonvested, Ending Balance	$ 10.95	$ 7.4

Leases (Tables)

12 Months Ended

Jun. 30, 2026

Leases [Abstract]

Schedule of Lease Expense and Supplemental Cash Flow Information

The components of lease expense for the fiscal years ended June 30, 2026 and 2025, were as follows (in thousands):


	Year ended June 30,
	2026		2025
Operating lease expense
Operating lease cost	$	1,742	$	1,881
Variable lease cost		119		154
Short-term lease costs		6		11
Total lease expense	$	1,867	$	2,046

Supplemental cash flow information related to operating leases was as follows (in thousands):


	Year ended June 30,
	2026		2025
Operating cash outflows from operating leases	$	2,187	$	2,284
Right-of-use assets obtained in exchange for lease obligations	$	176	$	—

Schedule of Maturity of Lease Liabilities

Maturity of lease liabilities at June 30, 2026 are as follows (in thousands):


Year ended June 30,	Amount
2027	$	2,223
2028		2,111
2029		1,772
2030		1,817
2031		1,862
Thereafter		943
Total		10,728
Less: imputed interest		(860	)
Present value of lease liabilities	$	9,868

Inventory

12 Months Ended

Jun. 30, 2026

Inventory Disclosure [Abstract]

Inventory

Note 4 — Inventory

Inventories consist of (in thousands):


	June 30, 2026				June 30, 2025
Finished goods	$	11,962	74.0	%	$	17,739	85.8	%
Raw materials		4,205	26.0	%		2,930	14.2	%
Total inventory	$	16,167	100.0	%	$	20,669	100.0	%

Reserves of inventories consist of the following (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	466		$	1,301
Additions		3,307			214
Write-offs		(634	)		(1,049	)
Ending balance	$	3,139		$	466

Other Expense, Net (Tables)

12 Months Ended

Jun. 30, 2026

Other Income and Expenses [Abstract]

Schedule of Other Expense, Net

Other expense, net consists of the following (in thousands):


	Year ended June 30,
	2026			2025
Foreign currency transaction loss, net	$	(200	)	$	(380	)
Other income (expense), net		2			(7	)
Total other expense, net	$	(198	)	$	(387	)

Segment Information (Tables)

12 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table presents the Company’s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2026 and 2025 (in thousands):


	Year ended June 30,
	2026			2025
Revenue, net	$	182,586		$	228,530
Cost of sales		(40,973	)		(44,864	)
Consultant commissions		(72,957	)		(95,920	)
Consultant incentives, promotions, and recognition		(4,137	)		(6,340	)
Labor and benefits		(26,958	)		(31,216	)
Stock compensation		(2,346	)		(5,702	)
Events		(4,065	)		(3,791	)
Depreciation and amortization		(2,773	)		(3,156	)
Credit card and bank processing fees		(5,187	)		(6,694	)
Other segment items(1)		(17,288	)		(19,035	)
Interest income		213			466
Interest expense		(49	)		(35	)
Income tax expense		(994	)		(2,438	)
Net income	$	5,072		$	9,805

(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.

Schedule of Long-lived Assets by Geographic Areas

The following table presents the Company’s long-lived assets for its most significant geographic markets (in thousands):


	June 30, 2026		June 30, 2025
United States	$	21,393	$	18,446
Foreign:
Japan		1,431		1,901
Other foreign markets		280		472
Total foreign markets		1,711		2,373
Total long-lived assets	$	23,104	$	20,819

Schedule of Revenue Disaggregated by Geographic Regions

The following table presents the Company’s revenue disaggregated by these markets (in thousands):


	Year ended June 30,
	2026		2025
United States	$	135,404	$	178,442
Foreign:
Japan		24,148		25,394
Other foreign markets		23,034		24,694
Total foreign markets		47,182		50,088
Total revenue, net	$	182,586	$	228,530

Disaggregation of Revenue

The following table shows revenue by product line for the fiscal years ended June 30, 2026 and 2025 (in thousands):


	Year ended June 30,
	2026		2025
Protandim® product line	$	81,989	$	95,328
TrueScience® product line		37,853		48,712
LifeVantage® product line		32,258		61,327
AXIO® product line		15,006		15,312
LoveBiome® product line		9,121		—
Petandim® product line		1,961		2,117
Other(1)		4,398		5,734
Total revenue, net	$	182,586	$	228,530

(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue, net	$ 182,586	$ 228,530
Cost of sales	40,973	44,864
Gross profit	141,613	183,666
Operating expenses:
Commissions and incentives	77,094	102,260
Selling, general and administrative	58,419	69,207
Total operating expenses	135,513	171,467
Operating income	6,100	12,199
Other income (expense):
Interest income, net	164	431
Other expense, net	(198)	(387)
Total other income (expense)	(34)	44
Income before income taxes	6,066	12,243
Income tax expense	(994)	(2,438)
Net income	$ 5,072	$ 9,805
Net income per share:
Basic (in USD per share)	$ 0.4	$ 0.8
Diluted (in USD per share)	$ 0.4	$ 0.75
Weighted-average shares outstanding:
Basic (in shares)	12,534	12,251
Diluted (in shares)	12,702	12,987
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	$ (699)	$ 741
Other comprehensive income (loss), net of tax	(699)	741
Comprehensive income	$ 4,373	$ 10,546

Segment Information - Schedule of Long Lived Assets (Details) - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 23,104	$ 20,819
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	21,393	18,446
Non-US
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	1,711	2,373
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	1,431	1,901
Other foreign markets
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 280	$ 472

Stockholders' Equity (Details) - USD ($)	3 Months Ended								12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jun. 30, 2026	Mar. 31, 2026	Dec. 31, 2025	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2026	Jun. 30, 2025	Jan. 31, 2026	Aug. 30, 2023
Class of Stock [Line Items]
Shares issued for stock option exercises (in shares)									0	0
Repurchase common stock amount authorized (up to)											$ 60,000,000
Stock repurchase program shares repurchased (in shares)									300,000	300,000
Shares repurchased									$ 2,000,000	$ 3,100,000
Remaining authorized repurchase amount	$ 58,500,000								58,500,000
Number of rights												1
Exercise price of rights (in dollars per share)												$ 20
Percent of common stock acquisition that makes rights exercisable												12.00%
Percent of common stock acquisition that makes rights exercisable, passive investors												20.00%
Discount percent												50.00%
Dividends, common stock, cash									$ 2,300,000	$ 2,100,000
Cash dividend paid (in dollars per share)	$ 0.05	$ 0.045	$ 0.045	$ 0.045	$ 0.045	$ 0.04	$ 0.04	$ 0.04	$ 0.185	$ 0.165
Common Stock
Class of Stock [Line Items]
Shares issued under equity award plan (in shares)									700,000	400,000
Shares canceled or surrendered as payment of tax withholding (in shares)									300,000	200,000

Property and Equipment, Net

12 Months Ended

Jun. 30, 2026

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Note 5 — Property and Equipment, Net

Property and equipment, net consist of (in thousands):


	June 30,
	2026			2025
Equipment (includes computer hardware and software)	$	20,436		$	16,998
Furniture and fixtures		1,467			1,469
Leasehold improvements		5,045			5,101
Vehicles		51			51
Accumulated depreciation		(19,689	)		(17,412	)
Total property and equipment, net	$	7,310		$	6,207

Depreciation expense totaled $2.4 million and $3.1 million for the fiscal years ended June 30, 2026 and 2025, respectively.

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
Cybersecurity Risk Management and Strategy Disclosure	Jun. 30, 2026
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	ITEM 1C — CYBERSECURITY Risk Management and Strategy We have implemented and maintain a cybersecurity risk management program that is designed to assess, identify, and manage material risks from cybersecurity threats. Our cybersecurity risk management processes are integrated into our broader enterprise risk management approach and are overseen through our security steering committee. The security steering committee includes representatives from functional areas such as: cybersecurity and infrastructure; corporate risk and privacy; personnel; and finance and fraud management. The security steering committee is responsible for reviewing cybersecurity risks, monitoring relevant risk trends, supporting prioritization of mitigation activities, and helping coordinate cross-functional responses when appropriate. The committee also supports the evaluation of risk associated with certain third-party service providers, including vendors and technology partners that may have access to Company systems, data, or infrastructure. We engage third parties, as appropriate, to assist in assessing, identifying, verifying, validating, and addressing cybersecurity risks. These third parties may include cybersecurity assessors, consultants, managed security service providers, auditors, and other external cybersecurity experts. We also use various security tools and processes designed to help identify, escalate, investigate, respond to, and recover from cybersecurity incidents in a timely manner. In addition, we provide periodic cybersecurity training to employees to help promote awareness of cybersecurity risks and reinforce employee responsibility in protecting our systems and information. Our cybersecurity program is intended to reduce risk, support operational resilience, and help protect the confidentiality, integrity, and availability of our systems and data. We have not identified risks from known cybersecurity threats to the business, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect our Company, including our business strategy, results of operations, or financial condition. See our risk factor “We are subject to evolving laws, policies, and contractual obligations related to data privacy and security, including cybersecurity, and our actual or perceived failure to comply with such obligations or perceived failure to maintain the integrity of our data could expose us to data loss or litigation, harm our reputation, subject us to significant fines and liability, or otherwise affect our business, prospects, financial condition, and operating results” and “Our development, deployment, use or integration of artificial intelligence technologies may present operational, competitive, legal, regulatory, cybersecurity, privacy, reputational and other risks, and may not achieve the benefits we expect.” in Part I, Item 1A. (“Risk Factors”) for additional details regarding cybersecurity risks and potential impacts on our business. Cybersecurity Governance Our board oversees the Company's risk management program, including risks related to cybersecurity. The board carries out its risk oversight responsibilities directly as a full board and, where appropriate, through its committees. The board has delegated to the audit committee primary oversight responsibility for risks and incidents relating to cybersecurity threats, including oversight of related disclosure considerations, cooperation with law enforcement where appropriate, and potential impacts on financial and operational risk. The audit committee receives updates from our Chief Technology Officer (“CTO”) regarding cybersecurity risk, program developments, incident response readiness, notable incidents, findings and recommendations, as appropriate. The audit committee reports material or notable cybersecurity matters to the full board for consideration, as appropriate. Management is responsible for assessing and managing material risk from cybersecurity threats. Our CTO has primary responsibility for overseeing the Company’s cybersecurity risk management program, including the prevention, detection, mitigation, and remediation of cybersecurity risks and incidents. The CTO is supported by internal information systems and cybersecurity personnel, members of the security steering committee, and third-party cybersecurity resources, as appropriate. Our CTO and other members of management are informed about cybersecurity risks through various means, which may include internal security reviews, reports from security tools deployed in the technical environment, updates from cybersecurity personnel, third-party assessments, vendor risk reviews, and incident response processes.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We have implemented and maintain a cybersecurity risk management program that is designed to assess, identify, and manage material risks from cybersecurity threats. Our cybersecurity risk management processes are integrated into our broader enterprise risk management approach and are overseen through our security steering committee.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Our board oversees the Company's risk management program, including risks related to cybersecurity. The board carries out its risk oversight responsibilities directly as a full board and, where appropriate, through its committees. The board has delegated to the audit committee primary oversight responsibility for risks and incidents relating to cybersecurity threats, including oversight of related disclosure considerations, cooperation with law enforcement where appropriate, and potential impacts on financial and operational risk.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The board carries out its risk oversight responsibilities directly as a full board and, where appropriate, through its committees.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The board has delegated to the audit committee primary oversight responsibility for risks and incidents relating to cybersecurity threats, including oversight of related disclosure considerations, cooperation with law enforcement where appropriate, and potential impacts on financial and operational risk.
Cybersecurity Risk Role of Management [Text Block]	The audit committee receives updates from our Chief Technology Officer (“CTO”) regarding cybersecurity risk, program developments, incident response readiness, notable incidents, findings and recommendations, as appropriate. The audit committee reports material or notable cybersecurity matters to the full board for consideration, as appropriate. Management is responsible for assessing and managing material risk from cybersecurity threats. Our CTO has primary responsibility for overseeing the Company’s cybersecurity risk management program, including the prevention, detection, mitigation, and remediation of cybersecurity risks and incidents. The CTO is supported by internal information systems and cybersecurity personnel, members of the security steering committee, and third-party cybersecurity resources, as appropriate. Our CTO and other members of management are informed about cybersecurity risks through various means, which may include internal security reviews, reports from security tools deployed in the technical environment, updates from cybersecurity personnel, third-party assessments, vendor risk reviews, and incident response processes.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	The audit committee receives updates from our Chief Technology Officer (“CTO”) regarding cybersecurity risk, program developments, incident response readiness, notable incidents, findings and recommendations, as appropriate.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our CTO has primary responsibility for overseeing the Company’s cybersecurity risk management program, including the prevention, detection, mitigation, and remediation of cybersecurity risks and incidents.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Leases [Abstract]
Operating cash outflows from operating leases	$ 2,187	$ 2,284
Right-of-use assets obtained in exchange for lease obligations	$ 176	$ 0

Intangible Assets Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Indefinite-Lived Intangible Assets [Line Items]
Accumulated amortization	$ (387)	$ 0
Total	2,813	0
Total intangible assets, net	3,058	245
Trademarks
Indefinite-Lived Intangible Assets [Line Items]
Trademarks and other indefinite-lived intangible assets	245	245
Trade name
Indefinite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	700	0
Know-how
Indefinite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	300	0
Consultant sales force
Indefinite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 2,200	$ 0

Acquisitions - Schedule of Unaudited Supplemental Information on a Proforma Basis (Details) - LoveBiome - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Business Combination, Pro Forma Information [Line Items]
Revenue	$ 185,124	$ 237,293
Earnings	$ 5,019	$ 10,158

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Acquisitions (Tables)

12 Months Ended

Jun. 30, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Summary of Preliminary Purchase Allocation

The following table summarizes the purchase price allocations relating to the business combination (in thousands):


	Valuation
Cash consideration paid	$	3,743
Earnout - current		200
Earnout - long-term		300
Total purchase price	$	4,243
Assets acquired:
Inventory	$	321
Other assets		257
Intangible assets		3,200
Total identifiable assets		3,778
Goodwill	$	465

Schedule of Intangible Assets Acquired

In connection with the acquisition of LoveBiome, the Company identified and valued the following intangible assets:


Category	Amount (in thousands)		Useful Life (Years)
Trade name	$	700		5
Know-how		300		5
Consultant sales force		2,200		7
Total acquired identifiable intangible assets(1)	$	3,200

(1) The fair value was determined using Level 3 assumptions.

Schedule of Unaudited Supplemental Information on a Proforma Basis

Unaudited supplemental information on a pro forma basis, as if the LoveBiome transaction had been consummated on July 1, 2024, is as follows (in thousands):


	Year ended June 30,
	2026		2025
Revenue	$	185,124	$	237,293
Earnings		5,019		10,158

- Definition

Tabular disclosure of business combination. Includes, but is not limited to, recognized asset and liability.

+ References + Details

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2026

Accounting Policies [Abstract]

Schedule of Property and Equipment, Net

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


				Years
Equipment				3 - 5
Furniture and fixtures				5
Vehicles				5

Property and equipment, net consist of (in thousands):


	June 30,
	2026			2025
Equipment (includes computer hardware and software)	$	20,436		$	16,998
Furniture and fixtures		1,467			1,469
Leasehold improvements		5,045			5,101
Vehicles		51			51
Accumulated depreciation		(19,689	)		(17,412	)
Total property and equipment, net	$	7,310		$	6,207

Schedule of Reconciliation of Net Income Per Share


	Year ended June 30,
	2026		2025
Numerator:
Net income	$	5,072	$	9,805
Denominator:
Basic weighted-average common shares outstanding		12,534		12,251
Effect of dilutive securities:
Stock awards and options		168		736
Diluted weighted-average common shares outstanding		12,702		12,987
Net income per share, basic	$	0.40	$	0.80
Net income per share, diluted	$	0.40	$	0.75

Segment Information - Narrative (Details) $ in Thousands		12 Months Ended
Segment Information - Narrative (Details) $ in Thousands	Oct. 01, 2025 Segment	Jun. 30, 2026 USD ($) ProductLine Region Segment	Jun. 30, 2025 USD ($) ProductLine
Segment Reporting Information [Line Items]
Number of reportable segments \| Segment		1
Number of operating segments \| Segment	1	1
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]		srt:ChiefExecutiveOfficerMember
Segment Reporting, Expense Information Used by CODM, Description		The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.
Number of geographic segments \| Region		2
Revenue \| $		$ 182,586	$ 228,530
Protandim®, TrueScience®, and LifeVantage®
Segment Reporting Information [Line Items]
Number of product lines \| ProductLine		3	3
Protandim®, TrueScience®, and LifeVantage® \| Revenue Benchmark \| Product Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk percentage		83.30%	87.60%
PhysIQ™ product line
Segment Reporting Information [Line Items]
Revenue \| $		$ 3,800	$ 5,100

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended						12 Months Ended
	Feb. 16, 2017	Nov. 30, 2025	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2020	Nov. 30, 2018	Feb. 28, 2018	Jun. 30, 2026	Jun. 30, 2025	Aug. 31, 2024	Jun. 30, 2024	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, net of awards expired (in shares)								72,000	72,000		72,000
Common stock issued under employee stock purchase plan (in shares)								35,000	44,000
Stock-based compensation								$ 2,346	$ 5,702
Options granted (in shares)								0	0
Compensation								$ 2,300	$ 5,700
Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards								1,300	4,400
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards								1,600	2,600
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested awards								$ 6,100	$ 1,100
Performance Restricted Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Distribution percentage of target number of Performance Stock Units												200.00%
Performance Restricted Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Distribution percentage of target number of Performance Stock Units												0.00%
2017 Long-Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)	650,000	400,000	1,138,000	1,052,000	650,000	715,000	425,000
Number of shares authorized (in shares)								5,505,000
Options outstanding, net of awards expired (in shares)								100,000
Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)								$ 4.44
Share based payment award, vesting period								3 years
Unrecognized compensation cost								$ 1,800
Period for recognition of unrecognized compensation cost								1 year 8 months 4 days
2010 Long-Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	475,000							475,000
Contractual term of stock options granted								10 years
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)								800,000		400,000
Shares available for issuance under the ESPP (in shares)								400,000
Purchase price of common stock (as a percent)								85.00%
Maximum employee subscription rate (as a percent)								15.00%
Maximum number of shares per employee (in shares)								3,000
Amount in excess of fair market value of stock for option not to be granted								$ 25
Offering period								6 months

Income Taxes - Deferred Tax Assets, Valuation Allowance Schedule (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ 642	$ 720
Decreases	(14)	(78)
Ending balance	$ 628	$ 642

Intangible Assets, Net - Schedule of Annual Amortization Expense (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
2027	$ 514
2028	514
2029	514
2030	514
2031	364
Thereafter	393
Total	$ 2,813	$ 0

Segment Information - Schedule of Segment Revenue and Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Segment Reporting Information [Line Items]
Revenue, net	$ 182,586	$ 228,530
Cost of sales	(40,973)	(44,864)
Stock compensation	(2,346)	(5,702)
Depreciation and amortization	(2,773)	(3,156)
Income tax expense	(994)	(2,438)
Net income	5,072	9,805
Reportable Segment
Segment Reporting Information [Line Items]
Revenue, net	182,586	228,530
Cost of sales	(40,973)	(44,864)
Consultant commissions	(72,957)	(95,920)
Consultant incentives, promotions, and recognition	(4,137)	(6,340)
Labor and benefits	(26,958)	(31,216)
Stock compensation	(2,346)	(5,702)
Events	(4,065)	(3,791)
Depreciation and amortization	(2,773)	(3,156)
Credit card and bank processing fees	(5,187)	(6,694)
Other segment items	(17,288)	(19,035)
Interest income	213	466
Interest expense	(49)	(35)
Income tax expense	(994)	(2,438)
Net income	$ 5,072	$ 9,805

Income Taxes - Effective Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Effective Income Tax Rate Reconciliation, Amount
Federal statutory income tax rate	$ 1,274
Domestic state and local income taxes, net of federal effect	214
Foreign tax rate differential	54
Non-taxable and non-deductible items
Meals and entertainment	95
Section 162(m) - Excess officer's compensation	137
Excess tax benefits on stock compensation	(250)
Other items, net	207
Non-taxable and non-deductible items, Total	189
Tax credits
Research and development credit	(555)
Foreign tax credit	(50)
Tax credits, Total	(605)
Cross-border tax laws, net	(131)
Change in valuation allowance	(1)
Worldwide changes in unrecognized tax benefits	0
Net income tax provision	$ 994	$ 2,438
The effective income tax rate differs from the U.S. Federal statutory income tax rate
Federal statutory income tax rate	21.00%	21.00%
Domestic state and local income taxes, net of federal effect	3.50%	3.40%
Foreign tax rate difference	0.90%	(0.40%)
Tax return to provision true-up		0.40%
Limit on future stock compensation due to 162(m)		4.00%
Foreign withholding tax		0.80%
Other differences		0.70%
Revalue of deferred for change in federal tax rate		0.00%
Cross-border tax laws, net	(2.10%)
Change in valuation allowance	0.00%	(0.40%)
Worldwide changes in unrecognized tax benefits	0.00%
Non-taxable and non-deductible items
Meals and entertainment	1.60%	0.60%
Section 162(m) - Excess officer's compensation	2.20%
Excess tax benefits on stock compensation	(4.10%)	(6.20%)
Other items, net	3.40%	0.70%
Non-taxable and non-deductible, Total	3.10%
Tax credits
Research and development credit	(9.20%)
Foreign tax credit	(0.80%)
Tax credits, Total	(10.00%)	(4.80%)
Permanent differences
- current year section 162(m) limitation		0.90%
- foreign derived intangible income deduction		(1.40%)
- removal of additional permanent reinvestment assertions		0.60%
- change in uncertain tax positions		(0.40%)
- accrual for foreign tax audits		0.40%
Net income tax provision	16.40%	19.90%

Other Expense, Net

12 Months Ended

Jun. 30, 2026

Other Income and Expenses [Abstract]

Other Expense, Net

Note 11 — Other Expense, Net

Other expense, net consists of the following (in thousands):


	Year ended June 30,
	2026			2025
Foreign currency transaction loss, net	$	(200	)	$	(380	)
Other income (expense), net		2			(7	)
Total other expense, net	$	(198	)	$	(387	)

Cover Page - USD ($) $ in Millions	12 Months Ended
Cover Page - USD ($) $ in Millions	Jun. 30, 2026	Aug. 26, 2026	Dec. 31, 2025
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2026
Current Fiscal Year End Date	--06-30
Document Transition Report	false
Entity File Number	001-35647
Entity Registrant Name	LIFEVANTAGE CORP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0224471
Entity Address, Address Line One	3300 N. Triumph Blvd
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Lehi
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84043
City Area Code	801
Local Phone Number	432-9000
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	LFVN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 63.7
Entity Common Stock, Shares Outstanding		12,527,348
Documents Incorporated by Reference	Portions of the registrant’s definitive proxy statement to be filed subsequent to the date hereof with the Securities and Exchange Commission pursuant to Regulation 14A in connection with the registrant’s fiscal year 2027 annual meeting of stockholders are incorporated by reference into Part III of this report. Such definitive proxy statement will be filed with the Commission not later than 120 days after the end of the registrant’s fiscal year ended June 30, 2026.
Entity Central Index Key	0000849146
Amendment Flag	false
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	FY
Document Financial Statement Error Correction [Flag]	false
Auditor Name	Deloitte & Touche LLP
Auditor Location	Salt Lake City, Utah
Auditor Firm ID	34
Auditor Opinion	Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated balance sheets of LifeVantage Corporation and subsidiaries (the “Company”) as of June 30, 2026 and 2025, the related consolidated statements of operations and comprehensive income, stockholders’ equity, and cash flows, for each of the two years in the period ended June 30, 2026, and the related notes (collectively referred to as the “financial statements”). We have also audited the Company’s internal control over financial reporting as of June 30, 2026, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of June 30, 2026 and 2025, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2026, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, 2026, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

Related Party Transactions - Narrative (Details) - Securities Purchase Agreement shares in Millions, $ in Millions	Feb. 23, 2026 USD ($) shares
Share Repurchase Program [Line Items]
Issued and outstanding shares own by related party \| shares	0.1
Shares repurchase price from related party \| $	$ 0.5
Minimum
Share Repurchase Program [Line Items]
Percentage of issued and outstanding shares own by related party	10.00%

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Pay vs Performance Disclosure
Net Income (Loss)	$ 5,072	$ 9,805

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Revenue (Tables)

12 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Abstract]

Schedule of Reserves for Sales Return

Reserves for sales returns consist of the following (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	237		$	133
Additions		2,385			2,759
Returns		(2,449	)		(2,655	)
Ending balance	$	173		$	237

Segment Information - Schedule of Revenue by Product Line (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Segment Reporting Information [Line Items]
Revenue, net	$ 182,586	$ 228,530
Protandim® product line
Segment Reporting Information [Line Items]
Revenue, net	81,989	95,328
TrueScience® product line
Segment Reporting Information [Line Items]
Revenue, net	37,853	48,712
LifeVantage® product line
Segment Reporting Information [Line Items]
Revenue, net	32,258	61,327
AXIO® product line
Segment Reporting Information [Line Items]
Revenue, net	15,006	15,312
LoveBiome Product Line
Segment Reporting Information [Line Items]
Revenue, net	9,121	0
Petandim® product line
Segment Reporting Information [Line Items]
Revenue, net	1,961	2,117
Other
Segment Reporting Information [Line Items]
Revenue, net	$ 4,398	$ 5,734

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Jun. 30, 2026

Accounting Policies [Abstract]

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of Estimates

Foreign Currency Translation

Fair Value of Financial Instruments

•

Level 1—Quoted prices for identical instruments in active markets;

•

Level 3—Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Our financial instruments, consisting primarily of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value due to their short-term nature.

Cash and Cash Equivalents

The Company considers only its monetary liquid assets with original maturities of three months or less as cash equivalents.

Concentration of Credit Risk

Accounts Receivable

Inventory

Property and Equipment

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


				Years
Equipment				3 - 5
Furniture and fixtures				5
Vehicles				5

Goodwill and Intangible Assets

Impairment of Long-Lived Assets

Shipping and Handling, Revenue And Deferred Revenue

Shipping and Handling

Revenue

Deferred Revenue

Commissions and Incentives

Research and Development Costs

Stock-Based Compensation

Income Taxes

Income Per Share


	Year ended June 30,
	2026		2025
Numerator:
Net income	$	5,072	$	9,805
Denominator:
Basic weighted-average common shares outstanding		12,534		12,251
Effect of dilutive securities:
Stock awards and options		168		736
Diluted weighted-average common shares outstanding		12,702		12,987
Net income per share, basic	$	0.40	$	0.80
Net income per share, diluted	$	0.40	$	0.75

New Accounting Pronouncements

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Current assets
Cash and cash equivalents	$ 14,920	$ 20,201
Accounts receivable	2,990	3,294
Income tax receivable	1,386	635
Inventory, net	16,167	20,669
Prepaid expenses and other	2,834	6,095
Total current assets	38,297	50,894
Non-current assets
Property and equipment, net	7,310	6,207
Right-of-use assets	6,715	8,041
Intangible assets, net	3,058	245
Goodwill	465	0
Deferred income tax asset	5,629	5,970
Other long-term assets	637	601
TOTAL ASSETS	62,111	71,958
Current liabilities
Accounts payable	5,156	4,600
Commissions payable	5,724	7,237
Lease liabilities	1,935	1,867
Other accrued expenses	7,412	13,513
Total current liabilities	20,227	27,217
Long-term lease liabilities	7,933	9,811
Other long-term liabilities	362	289
Total liabilities	28,522	37,317
Commitments and contingencies - Note 16
Stockholders’ equity
Preferred stock — par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding	0	0
Common stock - par value $0.0001 per share, 40,000 shares authorized and 12,518 and 12,429 issued and outstanding as of June 30, 2026 and June 30, 2025, respectively	1	1
Additional paid-in capital	138,924	139,962
Accumulated deficit	(103,462)	(104,147)
Accumulated other comprehensive loss	(1,874)	(1,175)
Total stockholders’ equity	33,589	34,641
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 62,111	$ 71,958

Segment Information - Schedule of Long-Lived Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Segment Reporting Information [Line Items]
Revenue, net	$ 182,586	$ 228,530
United States
Segment Reporting Information [Line Items]
Revenue, net	135,404	178,442
Non-US
Segment Reporting Information [Line Items]
Revenue, net	47,182	50,088
Japan
Segment Reporting Information [Line Items]
Revenue, net	24,148	25,394
Other foreign markets
Segment Reporting Information [Line Items]
Revenue, net	$ 23,034	$ 24,694

- Definition

+ References

+ Details

Share-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]
Options Outstanding, Beginning Balance	72,000	72,000
Options, Granted	0	0
Options, Exercised	0	0
Options, Forfeited	0	0
Options, Expired or Canceled	0	0
Options Outstanding, Ending Balance	72,000	72,000
Options, Exercisable	72,000
Weighted Average Exercise Price, Outstanding beginning balance	$ 4.44	$ 4.44
Weighted Average Remaining Contractual Term, Granted	0	0
Weighted Average Remaining Contractual Term, Exercised	0	0
Weighted Average Remaining Contractual Term, Forfeited	0	0
Weighted Average Remaining Contractual Term, Expired or Canceled	0	0
Weighted Average Exercise Price, Outstanding ending balance	4.44	$ 4.44
Weighted Average Exercise Price, Exercisable	$ 4.44
Weighted Average Remaining Contractual Term, Outstanding	1 year 7 months 2 days
Weighted Average Remaining Contractual Term, Exercisable	1 year 7 months 2 days
Aggregate Intrinsic Value, Exercised	$ 0	$ 0
Aggregate Intrinsic Value, Outstanding	129
Aggregate Intrinsic Value, Exercisable	$ 129

Segment Information

12 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Segment Information

Note 14 — Segment Information

The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets internationally. These products are purchased through third-party manufacturers by the Company's corporate office in the United States and sold to each international market. Pricing for all products is determined at the Company's corporate office in the United States. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company’s consolidated financial statements.

The Chief Operating Decision Maker (“CODM”) is the Company’s Chief Executive Officer. The CODM regularly reviews consolidated financial information and performance used to make decisions about the Company as a whole and without distinguishing or grouping of operations based on asset type, revenue, geographic location, tenant or other factors.

The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.

The following table presents the Company’s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2026 and 2025 (in thousands):


	Year ended June 30,
	2026			2025
Revenue, net	$	182,586		$	228,530
Cost of sales		(40,973	)		(44,864	)
Consultant commissions		(72,957	)		(95,920	)
Consultant incentives, promotions, and recognition		(4,137	)		(6,340	)
Labor and benefits		(26,958	)		(31,216	)
Stock compensation		(2,346	)		(5,702	)
Events		(4,065	)		(3,791	)
Depreciation and amortization		(2,773	)		(3,156	)
Credit card and bank processing fees		(5,187	)		(6,694	)
Other segment items(1)		(17,288	)		(19,035	)
Interest income		213			466
Interest expense		(49	)		(35	)
Income tax expense		(994	)		(2,438	)
Net income	$	5,072		$	9,805

(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.

The following table presents the Company’s long-lived assets for its most significant geographic markets (in thousands):


	June 30, 2026		June 30, 2025
United States	$	21,393	$	18,446
Foreign:
Japan		1,431		1,901
Other foreign markets		280		472
Total foreign markets		1,711		2,373
Total long-lived assets	$	23,104	$	20,819

The Company has identified two major markets with revenues exceeding 10% of consolidated total revenue: the United States and Japan. For the fiscal years ended June 30, 2026 and 2025, there are 17 and 16 other markets, respectively, each of which individually is less than 10% of consolidated total revenue. Sales are recorded in the market in which the transaction occurred. The following table presents the Company’s revenue disaggregated by these markets (in thousands):


	Year ended June 30,
	2026		2025
United States	$	135,404	$	178,442
Foreign:
Japan		24,148		25,394
Other foreign markets		23,034		24,694
Total foreign markets		47,182		50,088
Total revenue, net	$	182,586	$	228,530

Major Products

The Company’s revenue for the fiscal years ended June 30, 2026 and 2025 is largely attributed to three product lines: Protandim®, TrueScience®, and LifeVantage®. On a combined basis, these three product lines represent approximately 83.3% and 87.6% of the Company’s total net revenue for the fiscal years ended June 30, 2026 and 2025, respectively.

The following table shows revenue by product line for the fiscal years ended June 30, 2026 and 2025 (in thousands):


	Year ended June 30,
	2026		2025
Protandim® product line	$	81,989	$	95,328
TrueScience® product line		37,853		48,712
LifeVantage® product line		32,258		61,327
AXIO® product line		15,006		15,312
LoveBiome® product line		9,121		—
Petandim® product line		1,961		2,117
Other(1)		4,398		5,734
Total revenue, net	$	182,586	$	228,530

(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.

For the fiscal year ended June 30, 2026, the Company phased out the use of PhysIQ™ and placed this product under the LifeVantage® brand. During the fiscal years ended June 30, 2026 and 2025, revenue from PhysIQ™ was $3.8 million and $5.1 million respectively, and now included in the LifeVantage® product line revenue.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Inventory - Schedule Of Inventory Valuation Reserve (Details) - SEC Schedule, 12-09, Reserve, Inventory - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$ 466	$ 1,301
Additions	3,307	214
Write-offs	(634)	(1,049)
Ending balance	$ 3,139	$ 466

Other Accrued Expenses (Tables)

12 Months Ended

Jun. 30, 2026

Payables and Accruals [Abstract]

Schedule of Other Accrued Expenses

Other accrued expenses consist of (in thousands):


	June 30,
	2026		2025
Accrued incentive compensation	$	596	$	5,325
Accrued severance		3		5
Other taxes payable		1,693		2,189
Accrued payable to vendors		810		459
Deferred revenue		1,148		711
Accrued incentives and promotions to consultants		1,590		3,284
Accrued other expenses		1,572		1,540
Total other accrued expenses	$	7,412	$	13,513

Share-Based Compensation - Restricted Shares (Details) - $ / shares shares in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Restricted Stock Awards
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Nonvested, Beginning balance	156	392
Shares, Granted	81	58
Shares, Vested	(143)	(294)
Shares, Forfeited	(13)	0
Shares Nonvested, Ending Balance	81	156
Weighted Average Grant Date Fair Value, Nonvested, Beginning balance	$ 7.92	$ 4.74
Weighted Average Grant Date Fair Value, Granted	6.75	13.54
Weighted Average Grant Date Fair Value, Vested	8.19	4.77
Weighted Average Grant Date Fair Value, Forfeited	4.89	0
Weighted Average Grant Date Fair Value, Nonvested, Ending Balance	$ 6.75	$ 7.92
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Nonvested, Beginning balance	290	337
Shares, Granted	243	224
Shares, Vested	(160)	(224)
Shares, Forfeited	(153)	(47)
Shares Nonvested, Ending Balance	220	290
Weighted Average Grant Date Fair Value, Nonvested, Beginning balance	$ 8.68	$ 4.86
Weighted Average Grant Date Fair Value, Granted	9.95	10.08
Weighted Average Grant Date Fair Value, Vested	7.46	4.87
Weighted Average Grant Date Fair Value, Forfeited	11.82	6.12
Weighted Average Grant Date Fair Value, Nonvested, Ending Balance	$ 8.78	$ 8.68

Acquisitions - Narrative (Details) $ in Thousands		9 Months Ended	12 Months Ended
Acquisitions - Narrative (Details) $ in Thousands	Oct. 01, 2025 USD ($) Segment	Jun. 30, 2026 USD ($)	Jun. 30, 2026 USD ($) Segment	Jun. 30, 2025 USD ($)
Business Combination [Line Items]
Goodwill		$ 465	$ 465	$ 0
Number of operating segments \| Segment	1		1
Deferred income tax asset		5,629	$ 5,629	5,970
Change in fair value of earnout consideration			400	0
Amortization of acquired intangible assets			400	100
Revenue			182,586	$ 228,530
Measurement Input, Royalty Rate \| Trade name
Business Combination [Line Items]
Intangible asset, measurement input	0.015
Measurement Input, Royalty Rate \| Know-how
Business Combination [Line Items]
Intangible asset, measurement input	0.01
Measurement Input, Discount Rate \| Consultant sales force
Business Combination [Line Items]
Intangible asset, measurement input	0.285
LoveBiome
Business Combination [Line Items]
Goodwill	$ 465
Goodwill expected to be deductible for tax purposes		200	200
Deferred income tax asset		57	57
Earnout consideration		100	100
Acquisition-related costs			200
Revenue		$ 6,300
LoveBiome \| Selling, General and Administrative Expenses
Business Combination [Line Items]
Change in fair value of earnout consideration			400
Acquisition-related costs			$ 200

Leases - Schedule of Maturity of Lease Liabilities (Details) $ in Thousands	Jun. 30, 2026 USD ($)
Leases [Abstract]
2027	$ 2,223
2028	2,111
2029	1,772
2030	1,817
2031	1,862
Thereafter	943
Total	10,728
Less: imputed interest	(860)
Present value of lease liabilities	$ 9,868

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Deferred tax assets
Federal, state, and foreign net operating loss carryovers	$ 218	$ 234
Stock option compensation	332	628
Section 174 costs	3,099	2,798
Lease liability	2,538	2,798
Accrued vacation, allowance for returns, bonuses and other	2,849	2,819
Gross deferred tax asset	9,036	9,277
Deferred tax liabilities:
Patents and trademarks	(27)	(16)
Property & equipment	(170)	(239)
Right of use asset	(1,739)	(1,942)
Other	(843)	(468)
Gross deferred tax liabilities	(2,779)	(2,665)
Less: valuation allowance	(628)	(642)	$ (720)
Deferred tax assets, net	$ 5,629	$ 5,970

Inventory (Tables)

12 Months Ended

Jun. 30, 2026

Inventory Disclosure [Abstract]

Schedule of Components of Inventory

Inventories consist of (in thousands):


	June 30, 2026				June 30, 2025
Finished goods	$	11,962	74.0	%	$	17,739	85.8	%
Raw materials		4,205	26.0	%		2,930	14.2	%
Total inventory	$	16,167	100.0	%	$	20,669	100.0	%

Reserves of inventories consist of the following (in thousands):


	Year ended June 30,
	2026			2025
Beginning balance	$	466		$	1,301
Additions		3,307			214
Write-offs		(634	)		(1,049	)
Ending balance	$	3,139		$	466

Intangible Assets, Net (Tables)

12 Months Ended

Jun. 30, 2026

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Intangible assets, net consist of (in thousands):


	June 30,
	2026			2025
Trade name	$	700		$	—
Know-how		300			—
Consultant sales force		2,200			—
Accumulated amortization		(387	)		—
		2,813			—

Trademarks and other indefinite-lived intangible assets		245			245
Total intangible assets, net	$	3,058		$	245

Schedule of Annual Amortization Expense

Annual amortization expense expected for each of the five succeeding fiscal years is as follows (in thousands):


Year ended June 30,	Amount
2027	$	514
2028		514
2029		514
2030		514
2031		364
Thereafter		393
Total	$	2,813

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2024		12,510,000
Beginning balance at Jun. 30, 2024	$ 25,991	$ 1	$ 136,644	$ (108,738)	$ (1,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,702		5,702
Common stock issued under equity award plans (in shares)		376,000
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(202,000)
Shares canceled or surrendered as payment of tax withholding and other	(2,664)		(2,664)
Repurchase of company stock (in shares)		(299,000)
Repurchase of company stock	$ (3,147)			(3,147)
Common stock issued under employee stock purchase plan (in shares)	44,000	44,000
Common stock issued under employee stock purchase plan	$ 280		280
Cash dividends	(2,067)			(2,067)
Currency translation adjustment	741				741
Net income	$ 9,805			9,805
Ending balance (in shares) at Jun. 30, 2025	12,429,000	12,429,000
Ending balance at Jun. 30, 2025	$ 34,641	$ 1	139,962	(104,147)	(1,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,346		2,346
Common stock issued under equity award plans (in shares)		703,000
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(300,000)
Shares canceled or surrendered as payment of tax withholding and other	(3,616)		(3,616)
Forfeited restricted stock awards (in shares)		(13,000)
Repurchase of company stock (in shares)		(336,000)
Repurchase of company stock	$ (2,043)			(2,043)
Common stock issued under employee stock purchase plan (in shares)	35,000	35,000
Common stock issued under employee stock purchase plan	$ 232		232
Cash dividends	(2,344)			(2,344)
Currency translation adjustment	(699)				(699)
Net income	$ 5,072			5,072
Ending balance (in shares) at Jun. 30, 2026	12,518,000	12,518,000
Ending balance at Jun. 30, 2026	$ 33,589	$ 1	$ 138,924	$ (103,462)	$ (1,874)

Stock-Based Compensation

12 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Note 10 — Stock-Based Compensation

Long-Term Incentive Plans

Equity-Settled Plans

The Board of Directors adopted, and the Company’s stockholders approved, the 2017 Long-Term Incentive Plan (as amended, the “2017 Plan”), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. The initial number of shares reserved under the 2017 Plan was (i) 650,000 shares plus (ii) 475,000 shares previously reserved for issuance under the Company’s 2010 Long Term Incentive Plan (the “2010 Plan”), including upon cancellation, termination or forfeiture of awards previously granted under the 2010 Plan, plus (iii) shares subject to forfeited or terminated awards, or shares that are withheld or surrendered from an award to pay an award’s exercise price or tax withholding obligations, in each case where such awards have been granted under the 2017 Plan. In February 2018, November 2018, November 2020, November 2022, November 2023, and November 2025, the Company’s stockholders approved amendments to the 2017 Plan to increase the number of shares of the Company’s common stock that are available for issuance under the 2017 Plan by 425,000, 715,000, 650,000, 1,052,000, 1,138,000, and 400,000 shares, respectively. Further, in November 2024, the Company’s stockholders approved an amendment to remove individual grant limitations under the 2017 Plan and certain performance-based provisions, both of which are no longer applicable following the repeal of the performance-based exemption in Section 162(m) of the Internal Revenue Code, as amended. As of June 30, 2026, an aggregate of 5,505,000 shares of the Company’s common stock were authorized to be issued under the 2017 Plan, which includes up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan.

As of June 30, 2026, there were stock option awards outstanding under the 2017 Plan, net of awards expired, for an aggregate of 0.1 million shares of the Company’s common stock. Outstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three-year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted is generally ten years.

Employee Stock Purchase Plan

General. The Company’s 2019 ESPP was adopted by the Board of Directors in September 2018 and approved by the Company’s stockholders in November 2018. In August 2024, the Board of Directors approved an amendment to the 2019 ESPP to increase the share reserve thereunder by 0.4 million shares, which amendment and increase was approved by the Company’s stockholders in November 2024. The 2019 ESPP is intended to qualify under Section 423 of the Internal Revenue Code.

Share Reserve. The Company has reserved a total of 0.8 million shares of its common stock for issuance under the 2019 ESPP. As of June 30, 2026, 0.4 million shares were available for issuance. The number of shares reserved under the 2019 ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).

Purchase Price. Employees may purchase each share of common stock under the 2019 ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee’s contributions to the 2019 ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the 2019 ESPP if

such option would permit the participant’s rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.

Offering Periods. Unless otherwise determined by the compensation committee, the 2019 ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.

During the fiscal years ended June 30, 2026 and 2025, approximately 35,000 and 44,000 shares of common stock were issued under the 2019 ESPP, respectively.

Stock-Based Compensation

In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. For the fiscal years ended June 30, 2026 and 2025, stock-based compensation of $2.3 million and $5.7 million, respectively, was reflected as an increase to additional paid in capital. At June 30, 2026, there was $1.8 million of unrecognized compensation cost related to non-vested stock-based compensation arrangements under the 2017 Plan, based on management’s estimate of the shares that will ultimately vest. The Company expects to recognize such costs over a weighted-average period of 1.68 years.

Stock Options

There were no stock option grants during the fiscal years ended June 30, 2026 and 2025. The following is a summary of stock option activity for the fiscal years ended June 30, 2026 and 2025:


	Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2024		72	$	4.44

Granted		—		—
Exercised		—		—			$	—
Forfeited		—		—
Expired or Canceled		—		—
Outstanding at June 30, 2025		72		4.44

Granted		—		—
Exercised		—		—			$	—
Forfeited		—		—
Expired or Canceled		—		—
Outstanding at June 30, 2026		72		4.44		1.59	$	129
Exercisable at June 30, 2026		72	$	4.44		1.59	$	129

Restricted Stock Awards

The following is a summary of restricted stock award activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		392		$	4.74

Granted		58		$	13.54
Vested		(294	)		4.77
Forfeited		—			—
Nonvested at June 30, 2025		156			7.92

Granted		81		$	6.75
Vested		(143	)		8.19
Forfeited		(13	)		4.89
Nonvested at June 30, 2026		81			6.75

The total vesting date fair value of restricted shares that vested during the fiscal years ended June 30, 2026 and 2025 was $1.3 million and $4.4 million, respectively.

Restricted Stock Units

The following is a summary of restricted stock units activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		337		$	4.86

Granted		224		$	10.08
Vested		(224	)		4.87
Forfeited		(47	)		6.12
Nonvested at June 30, 2025		290			8.68

Granted		243		$	9.95
Vested		(160	)		7.46
Forfeited		(153	)		11.82
Nonvested at June 30, 2026		220			8.78

The total vesting date fair value of restricted stock units that vested during the fiscal years ended June 30, 2026 and 2025 was $1.6 million and $2.6 million, respectively.

Performance Restricted Stock Units

During the fiscal years ended June 30, 2026 and 2025, the Company awarded performance restricted stock units (the “FY 2026 PRSUs” and “FY 2025 PRSUs,” respectively) to certain employees (the “Recipients”). Each performance restricted stock unit represents a contingent right for the Recipients to receive a distribution of shares of common stock of the Company equal to 0% to 200% of the target number of performance restricted stock units subject to the award. The actual number of shares distributed will be based on the Company’s achievement of specified financial performance metrics. For FY 2026 PRSUs, the performance period for one-third of the FY 2026 PRSUs ended on June 30, 2026, the performance period for one-third of the FY 2026 PRSUs ends on June 30, 2027, and the performance period for the remaining one-third of the FY 2026 PRSUs ends on June 30, 2028. For FY 2025 PRSUs, the performance period for 50% of the FY 2025 PRSUs ended on June 30, 2025, the performance period for 30% of the FY 2025 PRSUs ended on June 30, 2026, and the performance period for the remaining 20% of the FY 2025 PRSUs ends on June 30, 2027.

The financial performance metrics for the fiscal year ended June 30, 2026, were deemed achieved at the 0% achievement level. The financial performance metrics for the fiscal year ended June 30, 2025, were deemed achieved at the 200% achievement level. The FY 2026 PRSUs and FY 2025 PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the Recipient’s continued service with the Company, as follows: (i) a portion of the earned award will vest on the first anniversary of the grant date and (ii) an additional portion of the earned award will vest thereafter in

a series of quarterly installments. The fair values of the performance restricted stock units are based on the grant date fair value which is the closing price of the Company's common stock on the date of grant.

The following is a summary of performance restricted stock units activity during the fiscal years ended June 30, 2026 and 2025:


	Shares (in thousands)			Weighted Average Grant Date Fair Value
Nonvested at June 30, 2024		284		$	4.62

Granted (1)		509		$	8.30
Vested		(94	)		4.24
Forfeited		(45	)		6.67
Nonvested at June 30, 2025		654			7.40

Granted		189		$	12.47
Vested		(462	)		7.25
Forfeited		(305	)		9.87
Nonvested at June 30, 2026		76			10.95

(1) Includes shares added based on achievement of performance goals in excess of target.

The total vesting date fair value of performance restricted stock units that vested during the fiscal years ended June 30, 2026 and 2025 was approximately $6.1 million and $1.1 million, respectively.

Property and Equipment, Net (Tables)

12 Months Ended

Jun. 30, 2026

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment, Net

Property and equipment are recorded at cost and depreciated using the straight-line method over the following useful lives:


				Years
Equipment				3 - 5
Furniture and fixtures				5
Vehicles				5

Property and equipment, net consist of (in thousands):


	June 30,
	2026			2025
Equipment (includes computer hardware and software)	$	20,436		$	16,998
Furniture and fixtures		1,467			1,469
Leasehold improvements		5,045			5,101
Vehicles		51			51
Accumulated depreciation		(19,689	)		(17,412	)
Total property and equipment, net	$	7,310		$	6,207